Genital herpes and public health: Addressing a global problem

JAMA

Volumn 283, Issue 6, 2000, Pages 791-794

  Corey, Lawrence ^a,b   Handsfield, H Hunter ^b,c  

^a Fred Hutchinson Cancer Center and University of Washington   (United States)

^b Department of Laboratory Medicine ^*  (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

GENITAL HERPES; GENITAL ULCER; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEWBORN INFECTION; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; VIRUS CULTURE; VIRUS TRANSMISSION;

EID: 0033961911     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.6.791     Document Type: Review

References (42)

1. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997;337:1105-1111.
2. Corey L. Wald A. Genital herpes. In:Holmes KK, Mårdh PA, Sparling PF, eds. Sexually Transmitted Diseases. 3rd ed. New York, NY: McGrawHill; 1999:285-312.
3. Catotti DN, Clarke P, Catoe KE. Herpes revisited: still a cause of concern. Sex Transm Dis. 1993;20:77-80.
4. Ross JD, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh, 1978-1991. Genitourin Med. 1993; 69:381-383.
5. Langenberg AGM, Corey L, Ashley RL, et al. A prospective study of new infections with HSV-1 and HSV-2. N Engl J Med. 1999;341:1532-1538.
6. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl. 1990;69:19-36.
7. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infection: clinical manifestations, course and complications. Ann Intern Med. 1983, 98:958-972.
8. Greenblatt RM, Lukehart SA, Plummer FA, et al. Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS. 1988;2:47-50.
9. Holmberg S, Stewart JA, Gerger AR, et al. Herpes simplex virus infection as a risk factor for HIV infection. JAMA. 1988;259:1048-1051.
10. Hook E, Connon RO, Nahmias AJ. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis. 1992;165:251-255.
11. Koutsky L, Stevens CE, Holmes KK, et al. Under diagnosis of genital herpes by current clinical and viral isolation procedures. N Engl J Med. 1992;326: 1533-1539.
12. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988;26:662-667.
13. Ashley RL, Eagleton M, Pfeiffer N. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol. 1999:37;1632-1633.
14. Johnson RE, Nahmias AJ, Magder LS, et al. A seroepidemiology survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1990;321:8-12.
15. Schacker T, Zeh J, Hu HL, et al. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis. 1998;178:1616-1622.
16. Forsgren M. Genital herpes simplex virus infections and incidence of neonatal disease in Sweden. Scand J Infect Dis. 1990;69(suppl 1):37-41.
17. International Herpes Management Forum. Report from the Sixth Annual Meeting of the IHMF. Herpes. 1999;6:1-27
18. Gwanzura L, McFarland W, Alexander D, et al. Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J Infect Dis. 1998; 177:481-484.
19. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337:509-515.
20. Langenberg A, Benedetti J, Jenkins J, et al. Development of clinically recognizable genital lesions among women previously identified as having asymptomatic herpes simplex virus type 2 infections. Ann Intern Med. 1989;110:882-887.
21. Diamond C, Selke S, Ashley R, Benedetti J, Corey L. Clinical course of patients with serological evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex Transm Dis. 1999;26:221-225.
22. Wald A, Corey L, Cone R, et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest. 1997;99:1092-1097.
23. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med. 1995;333: 770-775.
24. Benedetti JK, Zeh J, Corey L. Clinical reactivation of HSV-2 decreases in frequency over time. Ann Intern Med. 1999;131:14-20.
25. Mertz GJ, Coombs RW, Ashley RL, et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis. 1988;157:1169-1177.
26. Whitley RJ, Arvin AM Herpes simplex virus infections. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia, Pa: WB Saunders Co; 1995: 354-376.
27. Prober C, Sullender WM, Lew-Yasukawa L, et al. Low risk of herpes simplex infections in neonates exposed to virus at the time of vaginal delivery to mothers with recurrent genital HSV infections. N Engl J Med. 1987;316:240-244.
28. Brown ZA, Benedetti J, Ashley R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med. 1991;324:1247-1252.
29. Whitley RJ, Nahmias AJ, Soong SJ, et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics. 1980;66:495-501.
30. Whitley RJ, Arvin A, Prober CG, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 1991;324;444-449.
31. Marazzo JM, John GC, Krohn MA, Corey L. Cesarean delivery in women with genital herpes in Washington State, 1989-1991. Infect Dis Obstet Gynecol. 1997;5:29-35.
32. Castro KC, Lieb S, Jaffe HW, et al. Transmission of HIV in Belle Glade, Florida: lessons for other communities in the United States. Science 1988;238:193-197.
33. Dickerson M, Johnson J, Delea TE, et al. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus: an application of the Bradford Hill Criteria. Sex Transm Dis. 1996;23:429-440.
34. Mertz KJ, Trees D, Levine WC, et al. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. J Infect Dis. 1998;178:1795-1798.
35. Morse SA, Trees DL, Htun Y, et al. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis. 1997;175:583-589.
36. Schacker T, Ryncarz AJ, Goddard J, et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA. 1998: 280:61-66.
37. Mole L, Rapich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis. 1997; 176:766-770.
38. Fleming DT. Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
39. Corey L. Raising the consciousness for identifying and controlling viral STDs: fears and frustrations. Sex Transm Dis. 1998;25:58-69.
40. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124:8-15.
41. Schacker T, Hu HL, Koelle DM, et al. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. Ann Intern Med. 1998;128:21-28.
42. Handsfield HH, Stone KM, Wasserheit JW. Prevention agenda for genital herpes. Sex Transm Dis. 1999;26:228-231.